CEO MONTHLY Ι GLOBAL CEO EXCELLENCE AWARDS 2024 25 the healthcare sector, with tech giants such as Microsoft, Google, and Nvidia making strategic moves within the field. Such developments signify that AI in healthcare is indeed becoming more prevalent and more companies will be following suit in the years to come. To this extend, personalised medicine has reached a level of sophistication when combined with artificial intelligence. However, this partnership has also revealed notable drawbacks. Primarily, there being such a reliance on high quality, large-scale patient data for personalised treatments raises concerns over privacy protection, limiting the precision of care. An urgent challenge faced within the industry today is the balance between the benefits and costs of personalised treatment whilst alleviating the financial burden placed upon patients. There is much to be unfolded in regard to addressing these complex issues, with the evolution of AI in healthcare merely the tip of the iceberg. “Acknowledging the substantial distance yet to be traversed, Weiyun remains undaunted,” says Dapeng. “Armed with confidence and a steadfast commitment to our mission, we are resolute in our pursuit of realising this ambitious vision. The path ahead, while long, is illuminated by our unwavering belief in the transformative potential of our endeavours. We are dedicated to pioneering solutions that will redefine the accessibility and efficacy of medical treatments, ensuring that the benefits of AI are not merely a privilege but a universal reality.” Industrial AI is integral in streamlining healthcare; its integration can process voluminous healthcare data that encompasses patient records, diagnostic outcomes, and therapeutic regiments to optimise supply chain management and resource allocation. AI can power predictive analysis to empower clinicians to forecast patient needs and disease trajectories, in turn facilitating timely adjustments in clinical workflows and resource allocation. Ultimately, its integration can ensure that resources are provided efficiently and responsively in alignment with patient requirements, in addition to saving time and resources with effective management processes. Dapeng is driven by his belief that AI technology is the future, standing unequivocally as the beating heart of future industries across the board. It facilitates interconnected data sharing due to its fusion with the Internet of Things and big data analytics, which drives production processes towards intelligence, personalisation, and customisation. Such evolution perfectly accommodates the fluidity of market demands and business scenarios, making way for business models brimming with untapped potential. “Hence, I posit that evolution and adaption are intrinsic to the very fabric of theoretical frameworks,” says Dapeng. “As technology advances and its applications expand, a continuous cycle of practice and feedback is essential to refine and enhance AI capabilities. This adaptive resilience is critical to navigating the evershifting landscape of market environments. Such is the trajectory and vision that guides Weiyun AI & Robotics Group’s future course, anchoring our efforts in ongoing innovation and refinement to meet the exigencies of a changing world.” Moving forward, Dapeng plans to continue transforming and revolutionising the healthcare industry through the seamless integration of innovative industrial AI technologies. The technological pioneer remains steadfast in his commitment to reshaping the future of dentalcare, leveraging his expertise and passion for the field. Awarded the prestigious title of the Industrial AI CEO of the Year 2024, Dapeng has certainly made waves by bringing innovation to the very forefront of patientcare to change the lives of many. Contact Details Contact: Dapeng Liu Company: Ai Smile (HK) Limited (Weiyun AI & Robotics Group) Web Address: www. weiyunglobal.com
RkJQdWJsaXNoZXIy NTY1MjI4